Company intelligence / Profile preview

Cortechs.ai

San Diego, California, United Statescortechs.ai ↗

Ownership: Private
Development stage: Commercial

Overview

Cortechs.ai has developed FDA-cleared AI-powered medical device software such as NeuroQuant®, which quantifies brain structure volumes from MRI scans to aid in the diagnosis of neurodegenerative disorders. Their solutions are used in over 1,400 hospitals worldwide for clinical decision support in neurology and oncology. The company continues to expand its product suite into new disease areas including prostate cancer. Clinical results have established their tools as a gold standard for quantitative brain volume measurement.

Therapeutic areas: OncologyNeurology
Modalities: Device (medical imaging software)Non-pharmacological therapy (AI-powered diagnostics)Software as a medical device (SaMD)
Industry: Medical Imaging

Partnerships

Genting Berhad / Dragasac Limited (strategic investor)

Beyond the preview

Go deeper on Cortechs.ai.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cortechs.ai.

Explore the full profile